Alessandro Donada

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

MYC unchained: dosage-dependent locking of the myeloid fate (or not).

MYC unchained: dosage-dependent locking of the myeloid fate (or not).

Journal: Experimental hematology
Published: April 20, 2026

Clonal memory of cell division in humans diverges between healthy haematopoiesis and acute myeloid leukaemia.

Clonal memory of cell division in humans diverges between healthy haematopoiesis and acute myeloid leukaemia.

Journal: Nature communications
Published: July 11, 2025

Simultaneous Assessment of Kinship, Division Number, and Phenotype via Flow Cytometry for Hematopoietic Stem and Progenitor Cells.

Simultaneous Assessment of Kinship, Division Number, and Phenotype via Flow Cytometry for Hematopoietic Stem and Progenitor Cells.

Journal: Journal of visualized experiments : JoVE
Published: April 10, 2023

ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis.

ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis.

Journal: Haematologica
Published: September 05, 2022

Induced pluripotent stem cells and hematological malignancies: A powerful tool for disease modeling and drug development.

Induced pluripotent stem cells and hematological malignancies: A powerful tool for disease modeling and drug development.

Journal: Stem cell research
Published: March 02, 2020

The Pediatric Acute Leukemia Fusion Oncogene ETO2-GLIS2 Increases Self-Renewal and Alters Differentiation in a Human Induced Pluripotent Stem Cells-Derived Model.

The Pediatric Acute Leukemia Fusion Oncogene ETO2-GLIS2 Increases Self-Renewal and Alters Differentiation in a Human Induced Pluripotent Stem Cells-Derived Model.

Journal: HemaSphere
Published: August 05, 2019

Disrupted filamin A/αIIbβ3 interaction induces macrothrombocytopenia by increasing RhoA activity.

Disrupted filamin A/αIIbβ3 interaction induces macrothrombocytopenia by increasing RhoA activity.

Journal: Blood
Published: July 02, 2018

Clinic, pathogenic mechanisms and drug testing of two inherited thrombocytopenias, ANKRD26-related Thrombocytopenia and MYH9-related diseases.

Clinic, pathogenic mechanisms and drug testing of two inherited thrombocytopenias, ANKRD26-related Thrombocytopenia and MYH9-related diseases.

Journal: European journal of medical genetics
Published: August 25, 2017
Showing 1-8 of 8

Last Updated: 09/26/2026